| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 4,179 | 1,672 |
| Effect of foreign currency exchange rate changes on cash and cash equivalents | 1,963 | 1,831 |
| Net change in cash and cash equivalents | 28,442 | 12,031 |
| Cash and cash equivalents at beginning of period | 51,371 | - |
| Cash and cash equivalents at end of period | 79,813 | - |
AVADEL PHARMACEUTICALS PLC (AVDL)
AVADEL PHARMACEUTICALS PLC (AVDL)